PharMerica CORP 4
4 · PharMerica CORP · Filed Aug 12, 2014
Insider Transaction Report
Form 4
OAKLEY ROBERT A
Director
Transactions
- Sale
Common Stock, $0.01 par value
2014-08-08$26.55/sh−8,399$223,002→ 43,561 total - Exercise/Conversion
Common Stock, $0.01 par value
2014-08-08$16.16/sh+13,600$219,776→ 51,960 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-08-08−13,600→ 0 totalExercise: $16.16Exp: 2015-03-24→ Common Stock, $0.01 par value (13,600 underlying)
Footnotes (3)
- [F1]The shares were sold partially to cover the exercise cost of the options and the remaining shares were sold to cover the tax liability in connection with the exercise.
- [F2]Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $26.5410 and $26.5680. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
- [F3]The options vested in the following amounts on the following dates: 4,533 options on 03/24/2009, 4,533 options on 03/24/2010 and 4,534 options on 03/24/2011.